Matthew C. Cowperthwaite
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Matthew C. Cowperthwaite has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Anurekha Ramakrishnan
Sarah Cannon Rsch Institute, Austin, TX
3 shared publicationsMark G. Burnett
3 shared publicationsChristopher V Fanale
Swedish Med Cntr, Denver, CO
2 shared publicationsKevin Orndorff
HCA, Nashville, TN
2 shared publications- Max Shpak
Department of Medical Genetics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, USA
2 shared publications Zoltan Nadasdy
St. David’s Med Cntr, Austin, TX
2 shared publications
Latest Publications
- Open Access
- 7 August 2019
- Published by Springer Nature in BMC Medical Genomics
- Vol. 12 (1) , 1-15
Discovery of stroke-related blood biomarkers from gene expression network models
Identifying molecular biomarkers characteristic of ischemic stroke has the potential to aid in distinguishing stroke cases from stroke mimicking symptoms, as well as advancing the understanding of the physiological changes that underlie the body’s response to stroke. This study uses machine learning-based analysis of gene co-expression to identify transcription patterns characteristic of patients with acute ischemic stroke. Mutual information values for the expression levels among 13,243 quantified transcripts were computed for blood samples from 82 stroke patients and 68 controls to construct a co-expression network of genes (separately) for stroke and control samples. Page rank centrality scores were computed for every gene; a gene’s significance in the network was assessed according to the differences in their network’s pagerank centrality between stroke and control expression patterns. A hybrid genetic algorithm – support vector machine learning tool was used to classify samples based on gene centrality in order to identify an optimal set of predictor genes for stroke while minimizing the number of genes in the model. A predictive model with 89.6% accuracy was identified using 6 network-central and differentially expressed genes (ID3, MBTPS1, NOG, SFXN2, BMX, SLC22A1), characterized by large differences in association network connectivity between stroke and control samples. In contrast, classification models based solely on individual genes identified by significant fold-changes in expression level provided lower predictive accuracies: < 71% for any single gene, and even models with larger (10–25) numbers of gene transcript biomarkers gave lower predictive accuracies (≤ 82%) than the 6 network-based gene signature classification. miRNA:mRNA target prediction computational analysis revealed 8 differentially expressed micro-RNAs (miRNAs) that are significantly associated with at least 2 of the 6 network-central genes. Network-based models have the potential to identify a more statistically robust pattern of gene expression typical of acute ischemic stroke and to generate hypotheses about possible interactions among functionally relevant genes, leading to the identification of more informative biomarkers.
- 7 August 2019
- Published by Springer Nature in BMC Medical Genomics
- Vol. 12 (1) , 1-15
Open AccessDiscovery of stroke-related blood biomarkers from gene expression network models
Identifying molecular biomarkers characteristic of ischemic stroke has the potential to aid in distinguishing stroke cases from stroke mimicking symptoms, as well as advancing the understanding of the physiological changes that underlie the body’s response to stroke. This study uses machine learning-based analysis of gene co-expression to identify transcription patterns characteristic of patients with acute ischemic stroke. Mutual information values for the expression levels among 13,243 quantified transcripts were computed for blood samples from 82 stroke patients and 68 controls to construct a co-expression network of genes (separately) for stroke and control samples. Page rank centrality scores were computed for every gene; a gene’s significance in the network was assessed according to the differences in their network’s pagerank centrality between stroke and control expression patterns. A hybrid genetic algorithm – support vector machine learning tool was used to classify samples based on gene centrality in order to identify an optimal set of predictor genes for stroke while minimizing the number of genes in the model. A predictive model with 89.6% accuracy was identified using 6 network-central and differentially expressed genes (ID3, MBTPS1, NOG, SFXN2, BMX, SLC22A1), characterized by large differences in association network connectivity between stroke and control samples. In contrast, classification models based solely on individual genes identified by significant fold-changes in expression level provided lower predictive accuracies: < 71% for any single gene, and even models with larger (10–25) numbers of gene transcript biomarkers gave lower predictive accuracies (≤ 82%) than the 6 network-based gene signature classification. miRNA:mRNA target prediction computational analysis revealed 8 differentially expressed micro-RNAs (miRNAs) that are significantly associated with at least 2 of the 6 network-central genes. Network-based models have the potential to identify a more statistically robust pattern of gene expression typical of acute ischemic stroke and to generate hypotheses about possible interactions among functionally relevant genes, leading to the identification of more informative biomarkers.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (Suppl_1)
Abstract TP399: Identification of Risk Factors for Warning Bleeds in Patients With Spontaneous Subarachnoid Hemorrhage
Introduction: Identification of events preceding subarachnoid hemorrhage (SAH) could allow providers an opportunity to prevent SAH and improve outcomes for patients. Studies have suggested that SAH events are preceded by “warning bleeds” that produce symptoms such as migraines, however the results are contradictory and physicians have no indicators for warning bleeds. Hypothesis: We hypothesized that symptoms associated with an imminent SAH can be detected in emergency department (ED) visits preceding an SAH event. Methods: We studied 11,308 SAH visits that occurred at HCA hospitals between July 2011 and March 2016. A set of 10,000 ED encounters, matched by demographics (age, gender, race/ethnicity, location), was used as a control cohort. For each encounter, we pulled data for all ED or inpatient (IP) encounters within 30 days before the index SAH event. Data for each encounter include demographics, health history, diagnosis codes, and administered medications. Fisher Exact tests were used to study categorical variables; regression modeling was used to build models to assess patient risk. Results: 2,046 (18%) of all index SAH events were preceded with at least one ED or IP encounter within 30 days of the index event. 200 (9.8%) of the index SAH visits had a diagnosis of headache (including migraine), versus 2.7% in the controls (O.R. = 3.9; p < 0.01). Additionally, eye disorders, hereditary and degenerative nervous system conditions, coagulation and hemorrhagic disorders, and delirium/dementia/amnesia were all over-represented in the visits preceding SAH event (p < 0.01). Conclusions: Prior to SAH events, a proportion of patients present with ED or IP encounters associated with headaches, eye disorders, and dementia. It may be possible to use this information to develop a risk score for patients at imminent risk for an SAH and possibly reduce the incidence SAH.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (Suppl_1)
Abstract TP399: Identification of Risk Factors for Warning Bleeds in Patients With Spontaneous Subarachnoid Hemorrhage
Introduction: Identification of events preceding subarachnoid hemorrhage (SAH) could allow providers an opportunity to prevent SAH and improve outcomes for patients. Studies have suggested that SAH events are preceded by “warning bleeds” that produce symptoms such as migraines, however the results are contradictory and physicians have no indicators for warning bleeds. Hypothesis: We hypothesized that symptoms associated with an imminent SAH can be detected in emergency department (ED) visits preceding an SAH event. Methods: We studied 11,308 SAH visits that occurred at HCA hospitals between July 2011 and March 2016. A set of 10,000 ED encounters, matched by demographics (age, gender, race/ethnicity, location), was used as a control cohort. For each encounter, we pulled data for all ED or inpatient (IP) encounters within 30 days before the index SAH event. Data for each encounter include demographics, health history, diagnosis codes, and administered medications. Fisher Exact tests were used to study categorical variables; regression modeling was used to build models to assess patient risk. Results: 2,046 (18%) of all index SAH events were preceded with at least one ED or IP encounter within 30 days of the index event. 200 (9.8%) of the index SAH visits had a diagnosis of headache (including migraine), versus 2.7% in the controls (O.R. = 3.9; p < 0.01). Additionally, eye disorders, hereditary and degenerative nervous system conditions, coagulation and hemorrhagic disorders, and delirium/dementia/amnesia were all over-represented in the visits preceding SAH event (p < 0.01). Conclusions: Prior to SAH events, a proportion of patients present with ED or IP encounters associated with headaches, eye disorders, and dementia. It may be possible to use this information to develop a risk score for patients at imminent risk for an SAH and possibly reduce the incidence SAH.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (Suppl_1)
Abstract WP277: Stroke Triage and Diagnosis Processes Associated With Improved Door-to-Needle Time and tPA Rates
Introduction: The rapid diagnosis of an acute (AIS) ischemic stroke and determination of tPA eligibility requires efficient clinical processes and care coordination. Several quality initiatives have focused on door to needle time (DNT) and tPA rates, but few studies have investigated the impact of specific clinical-process elements on improving these quality metrics. Hypothesis: There are specific elements of triage and diagnosis processes that are associated with reduced DNT and higher tPA rates. Methods: A 42-item survey assessing the implementation times of 21 interventions was distributed to facilities in a large hospital system; median quarterly DNT and tPA rates were extracted for 2015-2017 for all hospitals surveyed. We compared the average DNT and tPA rates before and after implementation of the intervention using t-tests and ANOVA. When before-after comparisons were not possible, we compared the average DNT and tPA between facilities that implemented and did not implement the intervention. Results: 83 (47%) hospitals completed the survey. We found that strong predictors of post-intervention reduction of DNT (p < 0.01) included (i) implementation of pre-hospital communications with EMS, (ii) employment of a full-time stroke coordinator, (iii) bypassing the ED to go directly to a CT scan and (iv) pre-mixing tPA prior to CT. Including a pharmacist and registrar when responding to stroke alerts had the strongest effect on tPA rate (p < 0.01). Weaker effects on tPA rates were seen for implementations of point of care testing for different laboratory values and prioritizing the processing of labs orders for strokes. Conclusions: This study identified several interventions with the strong effect on DNT and tPA rates, suggesting these interventions could be prioritized at stroke centers. Our results also suggest some commonly cited clinical processes are not associated with shorted DNT and increased tPA rates.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (Suppl_1)
Abstract WP277: Stroke Triage and Diagnosis Processes Associated With Improved Door-to-Needle Time and tPA Rates
Introduction: The rapid diagnosis of an acute (AIS) ischemic stroke and determination of tPA eligibility requires efficient clinical processes and care coordination. Several quality initiatives have focused on door to needle time (DNT) and tPA rates, but few studies have investigated the impact of specific clinical-process elements on improving these quality metrics. Hypothesis: There are specific elements of triage and diagnosis processes that are associated with reduced DNT and higher tPA rates. Methods: A 42-item survey assessing the implementation times of 21 interventions was distributed to facilities in a large hospital system; median quarterly DNT and tPA rates were extracted for 2015-2017 for all hospitals surveyed. We compared the average DNT and tPA rates before and after implementation of the intervention using t-tests and ANOVA. When before-after comparisons were not possible, we compared the average DNT and tPA between facilities that implemented and did not implement the intervention. Results: 83 (47%) hospitals completed the survey. We found that strong predictors of post-intervention reduction of DNT (p < 0.01) included (i) implementation of pre-hospital communications with EMS, (ii) employment of a full-time stroke coordinator, (iii) bypassing the ED to go directly to a CT scan and (iv) pre-mixing tPA prior to CT. Including a pharmacist and registrar when responding to stroke alerts had the strongest effect on tPA rate (p < 0.01). Weaker effects on tPA rates were seen for implementations of point of care testing for different laboratory values and prioritizing the processing of labs orders for strokes. Conclusions: This study identified several interventions with the strong effect on DNT and tPA rates, suggesting these interventions could be prioritized at stroke centers. Our results also suggest some commonly cited clinical processes are not associated with shorted DNT and increased tPA rates.
- 1 October 2017
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Spine
- Vol. 27 (4) , 391-396
One-year outcomes of early-crossover patients in a cohort receiving nonoperative care for lumbar disc herniation
OBJECTIVE: The authors comprehensively studied the recovery course and 1-year outcomes of early-crossover patients who were randomized to the nonoperative care arm of the Leiden–The Hague Spine Intervention Prognostic Study. The primary goal was to gain insight into the differences in the recovery patterns of early-crossover patients and those treated nonoperatively; secondary goals were to identify predictors of good 1-year outcomes, and to understand when and why patients were likely to cross over.METHODS: Individual EuroQol-5D scores were obtained at baseline and at 2, 4, 8, 12, 26, 38, and 52 weeks for 142 patients. Early-crossover patients were defined as those electing to undergo surgery during the first 12 weeks of treatment. Crossover and noncrossover groups were compared using Kruskal-Wallis, Wilcoxon-Mann-Whitney, and chi-square tests. Linear mixed-effects models were used to examine the growth trajectories of crossover and noncrossover groups. Recursive partitioning trees were used to model crossover events and the timing of crossover decisions. Multivariable logistic regression models were used to identify predictors of good 1-year outcomes.RESULTS: Of the 142 patients randomized to receive prolonged nonoperative care, 136 were selected for the study. In this cohort, 43/136 (32%) opted for surgery, and 31/43 (72%) of crossover events occurred before the 12-week time point. Early-crossover patients had significantly greater functional impairment at Week 2 than noncrossover patients (p = 0.031), but experienced greater recovery by 26 weeks and better 1-year outcomes (p = 0.045). Patients who did not experience an improvement in their symptoms between 2 and 8 weeks were more likely to cross over (OR 3.5, 95% CI 1.2–10.1; p = 0.01). Recursive partitioning trees were able to identify crossover patients with 76% accuracy. Regression models suggested that better recovery at 26 weeks (p < 0.01) was predictive of good 1-year outcome; declining health status between Weeks 4 and 8 was negatively predictive of good outcome (p < 0.01).CONCLUSIONS: This study is the first to comprehensively analyze the recovery and outcomes of crossover patients, and compare them to nonoperatively treated patients. The results suggest that patients who have a low EuroQol-5D score during the early weeks of treatment and who do not respond to nonoperative care during the first few weeks of treatment are most likely to cross over. Early-crossover patients experience a greater rate of recovery and more frequently have a good 1-year outcome when compared with nonoperatively treated patients. The current results motivate a broader investigation into the timing of surgery and the identification of patient populations that will be most benefited by early surgical treatment for lumbar disc herniation.
- 1 October 2017
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Spine
- Vol. 27 (4) , 391-396
One-year outcomes of early-crossover patients in a cohort receiving nonoperative care for lumbar disc herniation
OBJECTIVE: The authors comprehensively studied the recovery course and 1-year outcomes of early-crossover patients who were randomized to the nonoperative care arm of the Leiden–The Hague Spine Intervention Prognostic Study. The primary goal was to gain insight into the differences in the recovery patterns of early-crossover patients and those treated nonoperatively; secondary goals were to identify predictors of good 1-year outcomes, and to understand when and why patients were likely to cross over.METHODS: Individual EuroQol-5D scores were obtained at baseline and at 2, 4, 8, 12, 26, 38, and 52 weeks for 142 patients. Early-crossover patients were defined as those electing to undergo surgery during the first 12 weeks of treatment. Crossover and noncrossover groups were compared using Kruskal-Wallis, Wilcoxon-Mann-Whitney, and chi-square tests. Linear mixed-effects models were used to examine the growth trajectories of crossover and noncrossover groups. Recursive partitioning trees were used to model crossover events and the timing of crossover decisions. Multivariable logistic regression models were used to identify predictors of good 1-year outcomes.RESULTS: Of the 142 patients randomized to receive prolonged nonoperative care, 136 were selected for the study. In this cohort, 43/136 (32%) opted for surgery, and 31/43 (72%) of crossover events occurred before the 12-week time point. Early-crossover patients had significantly greater functional impairment at Week 2 than noncrossover patients (p = 0.031), but experienced greater recovery by 26 weeks and better 1-year outcomes (p = 0.045). Patients who did not experience an improvement in their symptoms between 2 and 8 weeks were more likely to cross over (OR 3.5, 95% CI 1.2–10.1; p = 0.01). Recursive partitioning trees were able to identify crossover patients with 76% accuracy. Regression models suggested that better recovery at 26 weeks (p < 0.01) was predictive of good 1-year outcome; declining health status between Weeks 4 and 8 was negatively predictive of good outcome (p < 0.01).CONCLUSIONS: This study is the first to comprehensively analyze the recovery and outcomes of crossover patients, and compare them to nonoperatively treated patients. The results suggest that patients who have a low EuroQol-5D score during the early weeks of treatment and who do not respond to nonoperative care during the first few weeks of treatment are most likely to cross over. Early-crossover patients experience a greater rate of recovery and more frequently have a good 1-year outcome when compared with nonoperatively treated patients. The current results motivate a broader investigation into the timing of surgery and the identification of patient populations that will be most benefited by early surgical treatment for lumbar disc herniation.
- Open Access
- 28 September 2012
- Published by Hindawi Limited in ISRN Stroke
- Vol. 2012, 1-7
Quantifying the Contribution of Risk Factors for Ischemic Stroke in Patients with a History of TIA
Background. Patients with a history of transient ischemic attack (TIA) are known to be at higher risk for a stroke. We sought to investigate predictors of individual risk for an ischemic stroke within 30 days of a TIA. Methods and Results. A retrospective analysis of 57,585 TIA admissions was collected from 155 United States hospitals. Data describing each admission included demographic and clinical data, and information about the admitting hospital. Cerebrovascular disease was the primary readmission reason (19% of readmissions) in the TIA patient population. The prevalence of 30-day ischemic stroke readmissions was 11 per 1,000 TIA admissions; however, 53% of stroke readmissions occurred within one week. Hierarchal regression models suggested that peripheral vascular disease and hypertensive chronic kidney disease were significant individual stroke risk factors, whereas history of myocardial infarction, essential hypertension, and diabetes mellitus was not associated with significant stroke risk. Certified stroke centers were not associated with significantly lower stroke readmission rates. Conclusions. The results suggest that cardiovascular comorbidities confer the most significant risk for an ischemic stroke within 30 days of a TIA. Interestingly, certified stroke centers do not appear to be associated with significantly lower stroke-readmission rates, highlighting the challenges managing this patient population.
- 28 September 2012
- Published by Hindawi Limited in ISRN Stroke
- Vol. 2012, 1-7
Open AccessQuantifying the Contribution of Risk Factors for Ischemic Stroke in Patients with a History of TIA
Background. Patients with a history of transient ischemic attack (TIA) are known to be at higher risk for a stroke. We sought to investigate predictors of individual risk for an ischemic stroke within 30 days of a TIA. Methods and Results. A retrospective analysis of 57,585 TIA admissions was collected from 155 United States hospitals. Data describing each admission included demographic and clinical data, and information about the admitting hospital. Cerebrovascular disease was the primary readmission reason (19% of readmissions) in the TIA patient population. The prevalence of 30-day ischemic stroke readmissions was 11 per 1,000 TIA admissions; however, 53% of stroke readmissions occurred within one week. Hierarchal regression models suggested that peripheral vascular disease and hypertensive chronic kidney disease were significant individual stroke risk factors, whereas history of myocardial infarction, essential hypertension, and diabetes mellitus was not associated with significant stroke risk. Certified stroke centers were not associated with significantly lower stroke readmission rates. Conclusions. The results suggest that cardiovascular comorbidities confer the most significant risk for an ischemic stroke within 30 days of a TIA. Interestingly, certified stroke centers do not appear to be associated with significantly lower stroke-readmission rates, highlighting the challenges managing this patient population.
- 1 May 2011
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 18 (5) , 618-623
An analysis of admissions from 155 United States hospitals to determine the influence of weather on stroke incidence
- 1 May 2011
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 18 (5) , 618-623
An analysis of admissions from 155 United States hospitals to determine the influence of weather on stroke incidence
- Open Access
- 1 January 2011
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 68 (1) , 132-139
The Association Between Weather and Spontaneous Subarachnoid Hemorrhage: An Analysis of 155 US Hospitals
BACKGROUND:. A seasonal and meteorological influence on the incidence of spontaneous subarachnoid hemorrhage (SAH) has been suggested, but a consensus i
- 1 January 2011
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 68 (1) , 132-139
Open AccessThe Association Between Weather and Spontaneous Subarachnoid Hemorrhage: An Analysis of 155 US Hospitals
BACKGROUND:. A seasonal and meteorological influence on the incidence of spontaneous subarachnoid hemorrhage (SAH) has been suggested, but a consensus i
- 1 January 2010
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Neurosurgical Focus
- Vol. 28 (1) , E2
Genome-wide association studies: a powerful tool for neurogenomics
As their power and utility increase, genome-wide association (GWA) studies are poised to become an important element of the neurosurgeon's toolkit for diagnosing and treating disease. In this paper, the authors review recent findings and discuss issues associated with gathering and analyzing GWA data for the study of neurological diseases and disorders, including those of neurosurgical importance. Their goal is to provide neurosurgeons and other clinicians with a better understanding of the practical and theoretical issues associated with this line of research. A modern GWA study involves testing hundreds of thousands of genetic markers across an entire genome, often in thousands of individuals, for any significant association with a particular disease. The number of markers assayed in a study presents several practical and theoretical issues that must be considered when planning the study. Genome-wide association studies show great promise in our understanding of the genes underlying common neurological diseases and disorders, as well as in leading to a new generation of genetic tests for clinicians.
- 1 January 2010
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Neurosurgical Focus
- Vol. 28 (1) , E2
Genome-wide association studies: a powerful tool for neurogenomics
As their power and utility increase, genome-wide association (GWA) studies are poised to become an important element of the neurosurgeon's toolkit for diagnosing and treating disease. In this paper, the authors review recent findings and discuss issues associated with gathering and analyzing GWA data for the study of neurological diseases and disorders, including those of neurosurgical importance. Their goal is to provide neurosurgeons and other clinicians with a better understanding of the practical and theoretical issues associated with this line of research. A modern GWA study involves testing hundreds of thousands of genetic markers across an entire genome, often in thousands of individuals, for any significant association with a particular disease. The number of markers assayed in a study presents several practical and theoretical issues that must be considered when planning the study. Genome-wide association studies show great promise in our understanding of the genes underlying common neurological diseases and disorders, as well as in leading to a new generation of genetic tests for clinicians.